What is the optimal duration of anticoagulant therapy for patients with a first episode of unprovoked venous thromboembolism?
对于首次发生无端静脉血栓栓塞的患者,抗凝治疗的最佳持续时间是多长?
基本信息
- 批准号:387252
- 负责人:
- 金额:$ 7.65万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Studentship Programs
- 财政年份:2017
- 资助国家:加拿大
- 起止时间:2017-10-01 至 2020-10-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Venous thromboembolism (VTE) is a major cardiovascular disease comprising of blood clots in the leg veins and the lung vessels affecting more than 50,000 Canadians each year, and is third-leading cause of cardiovascular death. Unfortunately, more than 50%
静脉血栓栓塞(VTE)是一种主要的心血管疾病,包括腿部静脉和肺血管中的血栓,每年影响超过50,000名加拿大人,并且是心血管死亡的第三大原因。不幸的是,超过50%的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Khan Faizan其他文献
Khan Faizan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Khan Faizan', 18)}}的其他基金
Net Clinical Benefit and Cost-Effectiveness of Indefinite Anticoagulation Among Clinically Relevant Subgroups of Patients with First Unprovoked Venous Thromboembolism
首次无端静脉血栓栓塞临床相关亚组患者无限期抗凝的净临床效益和成本效益
- 批准号:
493128 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Co-Developing a Transitions in Care Bundle for Critically Ill Patients and Their Family Caregivers
共同开发危重病人及其家庭护理人员的护理过渡包
- 批准号:
471248 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
Fellowship Programs
Co-Developing a Transitions in Care Bundle for Critically Ill Patients and Their Family Caregivers
共同开发危重病人及其家庭护理人员的护理过渡包
- 批准号:
465810 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
Fellowship Programs
Cost-Effectiveness of Indefinite Versus Short-Term Anticoagulation for the Prevention of Recurrent Venous Thromboembolism in Unprovoked Venous Thromboembolism Patients
无限期抗凝与短期抗凝预防无端静脉血栓栓塞患者复发性静脉血栓栓塞的成本效益
- 批准号:
350194 - 财政年份:2015
- 资助金额:
$ 7.65万 - 项目类别:
Studentship Programs
相似海外基金
Evaluating equitable access to diabetic retinopathy screening using social value judgement informed distributional cost-effectiveness analyses (Oppression framework informed equity cost-effectiveness analysis of diabetic retinopathy screening)
使用社会价值判断知情的分配成本效益分析评估糖尿病视网膜病变筛查的公平性(压迫框架知情的糖尿病视网膜病变筛查公平成本效益分析)
- 批准号:
495212 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Modelling the Future of Home Health for Seniors - A Markov based Cost Effectiveness Analysis
模拟老年人家庭健康的未来 - 基于马尔可夫的成本效益分析
- 批准号:
484653 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Fellowship Programs
Cost-effectiveness analysis of systemic therapy for non-small cell lung cancer based on real-world data
基于真实数据的非小细胞肺癌全身治疗的成本效益分析
- 批准号:
23K17250 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Cost-effectiveness analysis of systematic screening for atrial fibrillation
房颤系统筛查的成本效益分析
- 批准号:
23K19868 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Algorithm development and cost-effectiveness analysis to optimize comprehensive environmental support for older adults
算法开发和成本效益分析,以优化老年人的综合环境支持
- 批准号:
22K10391 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cognitive Rehabilitation 'Mega Team' and its Effects on Emotional and Behavioural Regulation in Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and Congenital Heart Defect: a Cost-effectiveness Analysis
认知康复“超级团队”及其对注意力缺陷多动障碍、自闭症谱系障碍和先天性心脏病患者情绪和行为调节的影响:成本效益分析
- 批准号:
467243 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Studentship Programs
Determining if implementation of the haptoglobin phenotype biomarker should be tested in type 2 diabetes treatment planning to prevent cardiovascular disease: a biostatistical analysis, a cost-effectiveness analysis, and a patient priority analysis
确定是否应在 2 型糖尿病治疗计划中测试触珠蛋白表型生物标志物的实施以预防心血管疾病:生物统计分析、成本效益分析和患者优先分析
- 批准号:
458643 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Studentship Programs
Value of Information and Cost-Effectiveness Analysis to Optimize Research and Policy Decisions for HIV Care in Resource Limited Settings
信息和成本效益分析的价值,以优化资源有限环境下艾滋病毒护理的研究和政策决策
- 批准号:
10816834 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Value of Information and Cost-Effectiveness Analysis to Optimize Research and Policy Decisions for HIV Care in Resource Limited Settings
信息和成本效益分析的价值,以优化资源有限环境下艾滋病毒护理的研究和政策决策
- 批准号:
10652497 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Economic evaluation and cost-effectiveness analysis of cervical cancer preventative strategies by screening and vaccination in high HIV prevalence countries
在艾滋病毒高流行国家通过筛查和疫苗接种预防宫颈癌策略的经济评估和成本效益分析
- 批准号:
466695 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Studentship Programs